|
Subject: The trial is an extension of a 52-week, 3:1 randomised, pharm. Trial design:
The trial is a 26-week active controlled open label multicenter, multinational, two arm parallel groups, treat-to-target safety/efficacy trial.
The trial is an extension of a 52-week, 3:1 randomised, active controlled open label multicenter, multinational, two arm parallel groups, treat-to-target trial comparing the efficacy and safety of once daily SIBA with once daily insulin glargine both in a basal/bolus regimen with insulin aspart as mealtime insulin ± metformin ± pioglitazone in subjects diagnosed with type 2 diabetes
Подскажите, пожалуйста, как перевести "an extension of a 52-week, 3:1 randomised"?
|
